Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(10):786-788; doi:10.1093/jnci/92.10.786
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vastag, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vastag, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 10, 786-788, May 17, 2000
© 2000 Oxford University Press

NEWS

Detection Network Gives Early Cancer Tests a Push

Brian Vastag

At the apex of the Cold War, NATO deployed a net of high-powered radar stations along the frozen edge of North America, poised to alert commanders of approaching Soviet missiles. Designed to supply crucial minutes of warning, the sites sit ready but unused—watchdogs with no intruder.

In contrast, cancer researchers know their quarry but lack the know-how to construct a parallel early-warning system. For example, imaging technologies like MRI detect small cancers, but may not find precancerous cells. These cells look normal on the outside under the microscope but inside ferry a deadly warhead of genetic mutations. If there were ways to detect such renegades before they turned malignant, lives might be saved.

That’s the dream that drives a cadre of respected researchers in the nascent Early Detection Research Network (EDRN), a $20 million collection of 30 National . . . [Full Text of this Article]

Division of Labor

Share, Share Alike

Complexity Abounds


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
R. Danesi, F. De Braud, S. Fogli, T. M. De Pas, A. Di Paolo, G. Curigliano, and M. Del Tacca
Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer
Pharmacol. Rev., March 1, 2003; 55(1): 57 - 103.
[Abstract] [Full Text] [PDF]